Accessibility Menu
 
Regencell Bioscience logo

Regencell Bioscience

(NASDAQ) RGC

Current Price$28.58
Market Cap$14.13B
Since IPO (2021)+10,243%
5 YearN/A
1 Year+170%
1 Month-4%

Regencell Bioscience Financials at a Glance

Market Cap

$14.13B

Revenue (TTM)

$0.00

Net Income (TTM)

$8.90M

EPS (TTM)

$-0.01

P/E Ratio

-2012.68

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$28.58

Volume

119,751.65

Open

$26.51

Previous Close

$28.58

Daily Range

$26.51 - $30.00

52-Week Range

$7.89 - $83.60

RGC: Motley Fool Moneyball Superscore

26

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Regencell Bioscience

Industry

Pharmaceuticals

Employees

10

CEO

Yat-Gai Au

Headquarters

Causeway Bay, KY1-1107, HK

RGC Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-178%

Return on Capital

-5%

Return on Assets

-2%

Earnings Yield

-0.05%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$14.13B

Shares Outstanding

494.49M

Volume

119.75K

Avg. Volume

133.74K

Financials (TTM)

Gross Profit

$392.74K

Operating Income

$3.77M

EBITDA

$3.19M

Operating Cash Flow

$3.11M

Capital Expenditure

$152.69K

Free Cash Flow

$3.27M

Cash & ST Invst.

$4.90M

Total Debt

$544.41K

Regencell Bioscience Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$40.84K

N/A

Gross Margin

0.00%

N/A

Market Cap

$14.13B

N/A

Market Cap/Employee

$1.18B

N/A

Employees

12

N/A

Net Income

$5.32M

-514555.0%

EBITDA

$5.30M

-358.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$1.97M

-58.9%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$128.18K

N/A

Short Term Debt

$258.12K

N/A

Return on Assets

-2.34%

N/A

Return on Invested Capital

-5.29%

N/A

Free Cash Flow

$0.00

+100.0%

Operating Cash Flow

$0.00

+100.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AXSMAxsome Therapeutics, Inc.
$227.72-1.96%
CYTKCytokinetics, Incorporated
$75.85-3.55%
MASIMasimo Corporation
$178.47+0.07%
NUVLNuvalent, Inc.
$102.30-2.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$10.62-0.05%
INTCIntel
$108.77-0.06%
NOKNokia
$13.95-0.04%
FFord Motor Company
$13.40-0.07%

Questions About RGC

What is the current price of Regencell Bioscience?

Regencell Bioscience is trading at $28.58 per share.

What is the 52-week range for Regencell Bioscience?

Over the past 52 weeks, Regencell Bioscience has traded between $7.89 and $83.60.

How much debt does Regencell Bioscience have?

As of the most recent reporting period, Regencell Bioscience reported total debt of $544,415.

How much cash does Regencell Bioscience have on hand?

Regencell Bioscience reported $2.42M in cash and cash equivalents in its most recent financial results.

What is Regencell Bioscience’s dividend yield?

Regencell Bioscience does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.